Podcast Episodes
Back to Search
Carney’s tricky trade balancing act
Canadians braced for new tariffs on Wednesday. Instead, U.S. President Donald Trump said he would hold off on 50 per cent tariffs for three more days…
4 weeks, 1 day ago
Foreign actors target Alberta’s separatist referendum
New research from the University of Regina and the University of Alberta provides evidence that Russian content farms and right-wing U.S. influencers…
4 weeks, 2 days ago
The fate of ship crews stuck in the Strait of Hormuz
More than 6,000 ship workers, including some Canadians, have been stranded in the Persian Gulf — some in the Strait of Hormuz — since the war in Iran…
1 month ago
Ticks are spreading more than just Lyme disease
Canada is in the middle of one of its worst seasons for ticks. The tick population and tick-borne diseases are climbing year-over-year, and it’s not …
1 month ago
Skinny, Inc. Part 2: The big business of Ozempic
GLP-1 medications to treat diabetes, obesity and several other illnesses have exploded in popularity since Ozempic was approved for use in Canada bac…
1 month ago
What it’s like to flee the B.C. wildfires
Summerland, B.C., has been devastated by the Bald Range wildfire. More than 20,000 people have evacuated, and by Wednesday, it had burned 178 square …
1 month ago
Luluemon’s fight to stay on top of athleisure
For years, the Canadian athletic-wear brand Lululemon both pioneered and dominated the athleisure retail market. It turned workout gear into a status…
1 month ago
Canadian banks are going big on AI
Canadian banks are leaning heavily into AI adoption. More than 30 per cent of finance and insurance firms are using AI, compared to just 1.5 per cent…
1 month, 1 week ago
Making Halifax into Canada’s defence city
Steeped in military and naval history, Halifax is increasingly used as the backdrop for announcements of defence investment. The city is poised to be…
1 month, 1 week ago
Skinny, Inc. Part 1: The Canadian connection to Ozempic
Dr. Daniel Drucker’s research helped pave the way for Ozempic, the blockbuster GLP-1 class drug. The endocrinologist has been researching the effects…
1 month, 1 week ago